You are on page 1of 2

Volume 5, Issue 7, July – 2020 International Journal of Innovative Science and Research Technology

ISSN No:-2456-2165

Small Cell Neuroendocrine Carcinoma of


Tonsil – A Rare Occurrence
1.
Peoli Mukutawat, 2. Anil Kumar Dhull, 3. Vivek Kaushal, 4. Rakesh Dhankhar, 5. Rajeev Atri, 6. Kunwar Prativyom
Dr. Anita’s Diagnostic Realm, Sigra, Varanasi

Abstract originates in the tonsil is extremely rare and only a few


cases have been reported since it was first seen by Koss et
 Introduction: al. in 1972. Small cell neuroendocrine carcinoma of tonsil
Small cell neuroendocrine carcinomas of tonsil are carries a poor prognosis.3
extremely rare cancers and only a few cases have been
reported till date. They carry a poor prognosis. Neuroendocrine carcinoma is positive for
Paraneoplastic syndromes like SIADH, Cushing’s choromogranin A, synaptophysin and CD56 endocrine
syndrome and Eaton-Lambert myasthenic syndrome markers. A Ki67 or mitotic index of 20% or more is also
can be found associated with these carcinomas. The necessary for diagnosing NEC. Tumors with less than 20%
tumor can metastasize to liver, lungs, bone, brain and Ki67 positivity are diagnosed as neuroendocrine tumors.4
skin.
As of now, the treatment strategy for small cell
 Case Presentation: neuroendocrine carcinoma has not been properly
A 70-year-old male presented with a 2-month formulated due to the sparsity of data. Here we present a
history of pain in throat which was moderate to severe rare case of primary small cell neuroendocrine carcinoma
in intensity and intermittent.Local examination of arising from the tonsil.
oropharynx revealed a 5×5 cm ulcero-proliferative
growth over the right tonsil extending to right side of II. CASE PRESENTATION
base of tongue, vallecula, and right retromolar trigone.
Multiple matted lymph nodes were palpable in the right A 70-year-old male presented with a 2-month history
cervical region. Histopathological examination of tissue of pain in throat which was gradual in onset, progressive,
sample from the growth over the right tonsil revealed moderate to severe in intensity, intermittent, and with no
small cell neuroendocrine carcinoma. On aggravating or relieving factors. The patient was a chronic
immunohistochemistry, chromogranin and CD56 were smoker since 40-years. There was no history of any chronic
positive. Patient received 2-courses of neoadjuvant illness or history of cancer in the family and the patient was
chemotherapy with cisplatin and etoposide. Then the not receiving any medication.
patient was planned for external beam radiation
therapy with dose of 60 Gy in 30 fractions in 6 weeks. General physical examination and systemic
examination were normal. Local examination of
 Discussion: oropharynx revealed a 5×5 cm ulcero-proliferative growth
Small cell neuroendocrine carcinoma of tonsil are over the right tonsil extending to right side of base of
likely to be very aggressive with a tendency of tongue, vallecula, and right retromolar trigone. Multiple
developing early regional lymphatic and systemic matted lymph nodes were palpable in the right cervical
metastases. More research and clinical trials shall be region involving levels IB, II, III, and IV; largest lymph
explored to obtain a standard treatment strategy for node measuring 7×5 cm. Hematological and biochemical
these patients. profile were within normal limits. Chest X-ray was also
normal.
I. INTRODUCTION
CECT scan of face and neck revealed 5×4.5 cm
Neuroendocrine carcinoma (NEC) is a malignant heterogeneously enhancing lobulated soft tissue mass
epithelial cancer with neuroendocrinal morphology. Small lesion over the right tonsil with obliteration of right
cell neuroendocrine carcinomas are poorly differentiated tonsillo-lingual sulcus and extending to right side of base of
neuroendocrine tumors. They commonly originate in tongue and thickening of right lateral pharyngeal wall
pulmonary, gastrointestinal tract and genitourinary system. superiorly upto soft palate. Multiple enlarged lymph nodes
They have also been reported to occur in many other organs were noted in the right side of neck, largest being 6.5×5
throughout the body.1The incidence of small cell NEC is cm.
low in head and neck region. In head and neck region,
larynx is relatively most commonly involved site, followed A biopsy was taken from the growth over the right
by salivary glands, nasal cavity and paranasal tonsil and the histopathological examination revealed small
sinuses.2Small cell neuroendocrine carcinoma (NEC) that

IJISRT20JUL098 www.ijisrt.com 1
Volume 5, Issue 7, July – 2020 International Journal of Innovative Science and Research Technology
ISSN No:-2456-2165
cell neuroendocrine carcinoma. On immunohistochemistry,
chromogranin and CD56 were positive.

Patient received 2-courses of neoadjuvant


chemotherapy with injection cisplatin 150 mg and injection
etoposide 150 mg, intravenously. Thereafter the disease
had progressed in size and there was no response. Then the
patient was planned for external beam radiation therapy
with dose of 60 Gy in 30 fractions in 6 weeks.

III. DISCUSSION

Small cell neuroendocrine carcinomas of tonsil are


extremely rare cancers and only a few cases have been
reported since it was first seen by Koss et al. in 1972. They
carry a poor prognosis.3 They most commonly occur during
5th to 7th decade of life, and are more common in males
than in females (male : female ratio = 2:1). The patient
usually presents with a painless neck mass. Paraneoplastic
syndromes like SIADH, Cushing’s syndrome and Eaton-
Lambert myasthenic syndrome can be found associated
with these carcinomas.2 The tumor can metastasize to liver,
lungs, bone, brain and skin.5

The treatment options for small cell neuroendocrine


carcinoma of tonsil are chemotherapy, radiotherapy,
surgical resection or a combinations of these modalities.
Though, as of now, the treatment strategy for small cell
neuroendocrine carcinoma has not been properly
formulated due to the sparsity of data.

Small cell neuroendocrine carcinoma of tonsil are


likely to be very aggressive with a tendency of developing
early regional lymphatic and systemic metastases. Due to
this reason, it may be considered as a systemic disease.2
More research and clinical trials shall be explored to obtain
a standard treatment strategy for these patients.

REFERENCES

[1]. Jang H, Yuk SM, Kim JO, Han DS. A rare case of
primary malignant small cell carcinoma combined
with urothelial cell carcinoma in the ureter. World J
SurgOncol. 2013;11:181.
[2]. Renner G. Small cell carcinoma of the head and neck:
a review. SeminOncol. 2007;34:3–14.
[3]. Koss LG, Spiro RH, Hajdu S. Small cell (oat cell)
carcinoma of minor salivary gland
origin. Cancer. 1972;30:737–741.
[4]. Hou X, Wei JC, Wu JX, Wang X, Fu JH, Lin P, et al.
Multidisciplinary modalities achieve encouraging
long-term survival in resectable limited-disease
esophageal small cell carcinoma. PLoS One.
2013;8(7):e69259 Epub 2013/07/23.
[5]. Abedi E, Sismanis A: Extrapulmonary oat-cell
carcinoma of the tonsil. Ear Nose Throat J
1987;66:112– 115.

IJISRT20JUL098 www.ijisrt.com 2

You might also like